- Generic name
- Ondansetron
- Strength
- 8 mg
- Dosage form
- Tablet
- Manufactured by
- Rangs Pharmaceuticals Ltd.
Emitof 8 Tablet
About Emitof 8 Tablet
Emitof 8 comes as a tablet with 8 mg of Ondansetron, from Rangs Pharmaceuticals Ltd. Ask the doctor for details about your own treatment.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Emitof 8 Tablet?
Made by Rangs Pharmaceuticals Ltd., Emitof 8 is a tablet whose active ingredient is Ondansetron. Doctors use it to prevent nausea and vomiting linked to certain cancer treatments, radiotherapy, and after surgery. Its active ingredient is Ondansetron, which belongs to a group of medicines that block certain signals in the body that can trigger nausea and vomiting. The dose and course are decided by your doctor based on your condition.
Uses of Emitof 8
Ask the doctor for details about your own treatment. It is also used to prevent and treat nausea and vomiting that can happen after an operation, and to help prevent nausea and vomiting caused by radiotherapy. The doctor decides whether it is suitable and how it should be used.
How to use Emitof 8
Take Emitof 8 exactly as your doctor prescribes. Emitof 8 is taken by mouth. Swallow the tablet with water. The doctor decides the dose and the course, including how it fits around chemotherapy, radiotherapy or surgery. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Emitof 8
Tell the doctor about any side effect that worries you. Less common effects may include a feeling of warmth or flushing, hiccups, or changes in liver enzymes. If you experience any side effects, contact your doctor. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Use with caution after abdominal surgery or in patients with chemotherapy-induced nausea and vomiting, as it may mask signs of ileus or gastric distension. The safety of Emitof 8 in pregnancy and breastfeeding is not fully established; discuss with your doctor if you are pregnant, planning pregnancy, or breastfeeding. Pregnancy and breastfeeding should be discussed with the doctor first, as should liver problems and other medicines you take.
Frequently asked questions
What is Emitof 8 used for?
Ask the doctor for details about your own treatment. It is also used to prevent and treat nausea and vomiting that can happen after an operation, and to help prevent nausea and vomiting caused by radiotherapy.
How do I use Emitof 8 correctly?
Take Emitof 8 exactly as your doctor prescribes. Emitof 8 is taken by mouth.
Can Emitof 8 cause side effects?
Tell the doctor about any side effect that worries you. Less common effects may include a feeling of warmth or flushing, hiccups, or changes in liver enzymes.
Who should be careful with Emitof 8?
Use with caution after abdominal surgery or in patients with chemotherapy-induced nausea and vomiting, as it may mask signs of ileus or gastric distension. The safety of Emitof 8 in pregnancy and breastfeeding is not fully established; discuss with your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.